Libra Infusions Limited (DSE:LIBRAINFU)

Libra Infusions Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Feb 9, 2026	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015
Market Capitalization	1,599	1,310	1,534	653	760	422
Market Cap Growth	-14.08%	-14.61%	134.73%	-14.00%	80.01%	-19.29%
Enterprise Value	-	2,195	2,420	1,531	1,664	1,270
Last Close Price	709.70	579.08	678.16	287.16	332.21	183.29
PE Ratio	1009.29	826.64	266.35	107.37	130.53	97.96
PS Ratio	8.11	6.65	8.04	2.68	3.19	1.47
PB Ratio	0.84	0.69	0.81	0.33	0.39	0.21
P/TBV Ratio	0.84	0.69	0.81	0.33	0.39	0.21
P/FCF Ratio	-	-	4989.40	-	12.69	-
P/OCF Ratio	109.00	89.27	361.55	297.60	10.74	46.56
EV/Sales Ratio	-	11.14	12.69	6.27	6.99	4.43
EV/EBITDA Ratio	-	76.27	104.12	59.25	58.04	21.72
EV/EBIT Ratio	-	98.82	149.21	79.55	73.67	24.36
EV/FCF Ratio	-	-	7871.68	-	27.80	-
Debt / Equity Ratio	0.48	0.48	0.48	0.46	0.46	0.48
Debt / EBITDA Ratio	31.80	31.80	38.94	34.97	31.80	16.20
Debt / FCF Ratio	-	-	2943.56	-	15.24	-
Net Debt / Equity Ratio	0.47	0.47	0.47	0.45	0.45	0.48
Net Debt / EBITDA Ratio	31.30	31.30	38.55	34.59	30.68	16.04
Net Debt / FCF Ratio	-171.93	-171.93	2914.24	-68.08	14.70	-12.07
Asset Turnover	0.05	0.05	0.04	0.05	0.05	0.08
Inventory Turnover	1.59	1.59	1.54	2.21	1.78	1.60
Quick Ratio	0.22	0.22	0.03	0.03	0.03	0.03
Current Ratio	0.65	0.65	0.95	0.94	0.94	0.94
Return on Equity (ROE)	0.08%	0.08%	0.30%	0.31%	0.29%	0.22%
Return on Assets (ROA)	0.36%	0.36%	0.22%	0.26%	0.31%	0.86%
Return on Invested Capital (ROIC)	0.56%	0.56%	0.43%	0.49%	0.47%	1.00%
Return on Capital Employed (ROCE)	0.80%	0.80%	0.60%	0.70%	0.80%	1.90%
Earnings Yield	0.10%	0.12%	0.38%	0.93%	0.77%	1.02%
FCF Yield	-0.33%	-0.40%	0.02%	-2.01%	7.88%	-18.41%
Dividend Yield	-	0.06%	-	0.58%	0.42%	0.61%
Payout Ratio	0.58%	0.58%	33.93%	23.04%	28.24%	16.96%
Total Shareholder Return	-	0.06%	-	0.58%	0.42%	0.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.